At the BNA Festival of Neuroscience, we had the pleasure of speaking with Barry Everitt about his talk on ‘Addiction: a compulsive interplay between drugs, cues and habits’.
In a revolutionary approach, Cognetivity (London, UK) have created a new test for detecting dementia and Alzheimer’s disease by focusing on image cognition and the brain’s ability to analyze visual information.
In this interview, Anders Björklund speaks to us about how we might overcome the current limitations of using stem cell therapies for Parkinson’s disease.
In this interview, we spoke with Viviane Labrie about her research into the vermiform appendix as a possible contributor to Parkinson’s disease.
The BioTechniques editorial team talk to Jenny Straiton about her recent Tech News piece on cerebral organoids and the history of neuroscience.
Whilst at the AD/PD™ conference, we had the pleasure of speaking with Patrik Brundin about his talk on novel therapeutic targets for Parkinson’s disease.
Whilst at the ARUK Conference 2019, we had the pleasure of speaking with Hugh Perry about neuroinflammation and Alzheimer’s disease, particularly the role of microglia in brain homeostasis.
In this interview, we spoke with Alysson Muotri about defining cell maturity in brain organoids and how we could address the challenges with these systems.
In this interview, we spoke with Steven Cramer about regenerative stroke therapies, including the challenges involved with bringing these into the clinic.
For International Women’s Day, we spoke with Selina Wray to find out what more could be done to promote gender equality in science, including how we might involve more males in gender inequality discussions.